Orion Biotech Opportunities Corp. (ORIAU) Company Bio
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.
Orion Biotech Opportunities Corp. (the "Company") today announced the closing of its initial public offering ("IPO") of 20,000,000 units at a price of $10.00 per unit, resulting in total gross proceeds of $200,000,000. The Company's units began trading on The Nasdaq Capital Market (the "Nasdaq") under the symbol "ORIAU" on May 13, 2021.